On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...